Exagen to Participate in 2020 Cantor Fitzgerald Virtual Global Healthcare Conference
September 03 2020 - 4:05PM
Exagen Inc. (Nasdaq: XGN), an organization dedicated to
transforming the care continuum for patients suffering from
autoimmune diseases, today announced that its management team will
participate in the Cantor Fitzgerald Virtual Global Healthcare
Conference which takes place September 15-17, 2020. Ron
Rocca, President and CEO of Exagen, will engage in a fireside chat
on September 15 at 2:40 pm EDT.
A link to the live webcast of Mr. Rocca’s fireside chat will be
available online from the investor relations section of the Exagen
website at https://investors.exagen.com/ . Following the live
webcast, a replay of the event will be archived on the Exagen
website for approximately 90 days.
About Exagen Inc.
Exagen is dedicated to transforming the care continuum for
patients suffering from debilitating and chronic autoimmune
diseases by enabling timely differential diagnosis and optimizing
therapeutic intervention. Exagen has developed and is
commercializing a portfolio of innovative testing products under
its AVISE® brand, several of which are based on its proprietary
Cell-Bound Complement Activation Products, or CB-CAPs, technology.
Exagen’s goal is to enable rheumatologists to improve care for
patients through the differential diagnosis, prognosis and
monitoring of complex autoimmune and autoimmune-related diseases,
including SLE and rheumatoid arthritis.
CONTACTS:
InvestorsWestwicke Partners Mike
CavanaughMike.Cavanaugh@westwicke.com646.677.1838 Company
ContactExagen Inc. Kamal Adawi, Chief Financial
OfficerKAdawi@exagen.com760.477.5514
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exagen (NASDAQ:XGN)
Historical Stock Chart
From Apr 2023 to Apr 2024